Investing.com - Financial Markets Worldwide
🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

Bristol-Myers Squibb earnings beat by $0.22, revenue topped estimates

Published 2023-10-26, 07:09 a/m
© Reuters. Bristol-Myers Squibb earnings beat by $0.22, revenue topped estimates
BMY
-

Investing.com - Bristol-Myers Squibb (NYSE: BMY) reported third quarter EPS of $2.00, $0.22 better than the analyst estimate of $1.78. Revenue for the quarter came in at $11B versus the consensus estimate of $10.98B.

Guidance

Bristol-Myers Squibb sees FY 2023 EPS of $7.50-$7.65 versus the analyst consensus of $7.36.

Bristol-Myers Squibb's stock price closed at $56.61. It is down -7.82% in the last 3 months and down -24.12% in the last 12 months.

Bristol-Myers Squibb saw 0 positive EPS revisions and 20 negative EPS revisions in the last 90 days. See Bristol-Myers Squibb's stock price’s past reactions to earnings here.

According to InvestingPro, Bristol-Myers Squibb's Financial Health score is "great performance".

Check out Bristol-Myers Squibb's recent earnings performance, and Bristol-Myers Squibb's financials here.

Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar

Latest comments

Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.